(Q40161943)

18 September 2017

1 reference

title

Ticlopidine hydrochloride: relationship between dose, kinetics, plasma concentration and effect on platelet function (English)

1 reference

18 September 2017

Ticlopidine hydrochloride: Relationship between dose, kinetics, plasma concentration and effect on platelet function (English)

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90367-5

6 October 2023

author name string

C. Picard-Fraire

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6356462

6 October 2023

language of work or name

1 reference

1 January 1983

1 reference

full work available at URL

18 September 2017

https://api.elsevier.com/content/article/PII:0049384883903675?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90367-5

https://api.elsevier.com/content/article/PII:0049384883903675?httpAccept=text/plain

6 October 2023

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90367-5

Thrombosis Research. Supplement

6 October 2023

published in

1 reference

18 September 2017

volume

4

1 reference

18 September 2017

page(s)

119-128

1 reference

Effects of ticlopidine, a new platelet aggregation inhibitor in man

18 September 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90367-5

The effect of ticlopidine on platelet function in normal volunteers and in patients with platelet hyperaggregability

6 October 2023

3

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90367-5

Ticlopidine - an antiplatelet drug: effects in human volunteers

6 October 2023

4

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90367-5

Compared effects of three dose-levels of ticlopidine on platelet function in normal subjects

6 October 2023

5

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90367-5

Antiaggregatory, physiological and clinical effects of ticlopidine in subjects with peripheral atherosclerosis

6 October 2023

6

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90367-5

The effect of ticlopidine administration to humans on the binding of adenosine diphosphate to blood platelets

6 October 2023

7

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90367-5

Experimental model of venous thrombosis in rats and effect of some agents.

6 October 2023

20

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90367-5

Anti-thrombotic action of ticlopidine, a new platelet aggregation inhibitor

6 October 2023

22

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90367-5

Antithrombotic therapy with ticlopidine in chronic renal failure patients on maintenance hemodialysis--a multicenter collaborative double blind study

6 October 2023

26

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90367-5

Metabolism of ticlopidine in rats: identification and quantitative determination of some its metabolites in plasma, urine and bile

6 October 2023

33

1 reference

https://api.crossref.org/works/10.1016/0049-3848(83)90367-5

6 October 2023

Identifiers

1 reference

18 September 2017

1 reference